Brigatinib plus carboplatin–pemetrexed after lorlatinib failure in ALK-rearranged non-small cell lung cancer with co-occurring ALK I1171N and G1269A mutations: a case report
Year: 2026
Type: article
Study design: Case Report
Source: Journal of Chemotherapy
Institution: Marmara University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7234709756
